Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.
about
Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.Astatine Radiopharmaceuticals: Prospects and ProblemsCombining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.Phage display and molecular imaging: expanding fields of vision in living subjects.Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imagingIn vivo targeting of HER2-positive tumor using 2-helix affibody molecules.In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging.Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumorsGeneration of affibody molecules specific for HPV16 E7 recognitionMolecular imaging of insulin-like growth factor 1 receptor in cancer.HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.Protein-based tumor molecular imaging probes.Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody moleculesUsing in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.Radiolabeling of HER2 specific Affibody(R) molecule with F-18.Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.Targeting the EGF receptor ectodomain in the context of cancer.Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.Molecular imaging for guiding oncologic prognosis and therapy in esophageal adenocarcinoma.Antibody fragments as tools in crystallography.Future and advances in endoscopy.Molecular imaging with SERS-active nanoparticles.Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects.The role of nuclear medicine in modern therapy of cancer.Image-guided nanosystems for targeted delivery in cancer therapy.Molecular imaging in gastroenterology.Design and evaluation of radiolabeled tracers for tumor imaging.Imaging EGFR and HER2 by PET and SPECT: a review.Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently.Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.Engineering and functionalization of the disulfide-constrained miniprotein min-23 as a scaffold for diagnostic application.Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy.Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
P2860
Q30436623-96A7B371-8886-4DDD-B4CD-5DF5A91267E1Q33330736-A14833B5-45D8-4E05-B545-3A0B6DB9B554Q33640550-D4F571D5-2BE9-4AF2-BC47-53A0EEB746ACQ33777866-0DCA2D38-504A-4436-83D7-946E57785101Q33849788-4281E65C-BAB9-4673-AE58-A7CF40A09618Q33921086-DA9556D0-0A53-4BBE-80C4-647B6125CD0CQ34231627-DEEC9EE6-95DD-48E0-8D7A-34F914D85119Q35803276-70936DDB-62D3-4F08-82C9-4DC0D885530FQ35851983-2AE3725B-4C51-4DAE-BD12-032F1463F3CBQ36100348-906ED17C-9D3B-4D69-8C12-DF0EE88DA0D9Q36108466-D4540F47-B324-4604-82C2-7EA2D9203AD6Q36141929-3A4E7F95-46C8-4497-B969-61588698712BQ36337268-BD73465A-3517-4742-8298-F7F06FC7FB31Q36448817-1CCBE89F-A360-4C0F-AE39-05E54960333EQ36627997-18BCB3E3-743B-4C74-8D90-2F44E674869AQ36742911-5BFC5617-ABD0-4D1E-83AB-EBB8ADFC2186Q36922818-E212AE5D-191D-4EE5-8B2A-5D98E1933E1EQ37031461-EDA1EADE-EE0E-41D0-8E2E-777B72FF13B9Q37071060-9BAFB726-6F57-47AE-BA7B-94C0C76C2FDCQ37220415-B7049A4E-CAFD-4624-A6B0-599BDAFBF1C9Q37600910-44CFABE3-D633-44F6-AD82-3F2B92149A4CQ37730252-3FDABFBA-BBF6-4ECB-B96C-C4958DFB9B07Q37876081-3A25820F-1951-498D-A38C-4C6DEAF0EC33Q37886029-EA9079ED-1C91-4355-BE10-CB1DABDDB8C4Q37900565-10C2824E-DE18-429D-A79A-499FB0417E7BQ37935679-6C0A851F-3970-4A43-9CDE-9EEE14DD9B49Q37972851-DF5C9750-706A-4B69-84D0-A7FF19DAD024Q37996849-938AB51C-BA69-46A7-B497-199ED135942EQ38011794-6F49714E-5214-45F9-AD7E-72BDCD508503Q38121747-9D5A5E91-4C41-46A3-B86A-448E71390B2CQ38137253-A021EB41-261D-4AF2-9B49-957BA8795C62Q38137829-5FB70605-39A4-4D3C-B073-71C9A75B951FQ38287400-A71575D0-CC80-4F08-A19D-8A1C05352760Q38820756-5AEB0B0C-2600-404C-B0E9-D0D6790060A0Q38922319-ECE7571D-81AE-4488-A331-E33985BA539FQ39974009-BD5C047A-6C6F-472C-A4F7-943F37DD7A6BQ40976323-200DFD4A-A925-4ACC-9CD6-04ECEEC4F86EQ45107054-C4E2D718-F99A-41BA-9B72-7F7BA452AE86Q47813155-E4E8CBEB-0A7A-45A7-B3B5-1AB7993D604CQ47928453-95DB435F-1BD5-4D10-902C-C0CF64757F26
P2860
Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Affibody molecules: potential ...... ar targets for cancer therapy.
@ast
Affibody molecules: potential ...... ar targets for cancer therapy.
@en
Affibody molecules: potential ...... ar targets for cancer therapy.
@nl
type
label
Affibody molecules: potential ...... ar targets for cancer therapy.
@ast
Affibody molecules: potential ...... ar targets for cancer therapy.
@en
Affibody molecules: potential ...... ar targets for cancer therapy.
@nl
prefLabel
Affibody molecules: potential ...... ar targets for cancer therapy.
@ast
Affibody molecules: potential ...... ar targets for cancer therapy.
@en
Affibody molecules: potential ...... ar targets for cancer therapy.
@nl
P2093
P2860
P356
P1476
Affibody molecules: potential ...... ar targets for cancer therapy.
@en
P2093
Anders Wennborg
Anna Orlova
Fredrik Y Nilsson
Joachim Feldwisch
Lars Abrahmsén
P2860
P304
P356
10.1517/14712598.7.4.555
P407
P577
2007-04-01T00:00:00Z